Empowering drug discovery scientists with the latest advances in AI-enabled drug design
Location: Canada, Montreal (06), Montreal
Total raised: $17M
Investors 11
Show more
Funding Rounds 2
| Date | Series | Amount | Investors |
| 25.02.2022 | Seed | $8.5M | - |
| 15.12.2021 | Seed | $8.5M | - |
Mentions in press and media 4
| Date | Title | Description |
| 31.07.2023 | 4 Ways Biopharma Is Applying AI/ML to Improve Drug Development Outcomes | Healthcare innovation in drug development intersects with a few critical trends: the rise of artificial intelligence (AI) applications in healthcare—particularly machine learning (ML) and predictive analytics; the need to reduce the costs a... |
| 25.02.2022 | Valence Discovery Announces $8.5 Million in Seed Funding to Scale AI-Based Generative Chemistry Engine and Collaborations with Leading Discovery Organizations | Valence’s AI-based generative chemistry engine designs novel chemical matter optimized for complex property profiles against high-value disease targets even in the absence of experimental data |
| 15.12.2021 | Valence Discovery announces $10.9 million CAD for AI-aided drug discovery and formulation | Housed in Montréal’s renowned Mila artificial intelligence (AI) research institute, AI startup Valence Discovery recently came out of stealth mode earlier this year and announced $10.9 million CAD ($8.5 million USD) in funding. The startup ... |
| 15.12.2021 | Valence Discovery Announces $8.5 Million in Seed Funding to Scale AI-Based Generative Chemistry Engine and Collaborations with Leading Discovery Organizations | Valence Discovery (“Valence”), a leader in AI-first design of novel chemistry against previously intractable biology, announced today that it has closed an oversubscribed US$7 million seed financing. The financing, which was co-led by Fifty... |